Search

Displaying results 1 - 10 of 46 in total
  1. Indication

    Secondary humoral immunodeficiency

    go.drugbank.com/conditions/DBCOND0150607
    Drugs: Human immunoglobulin G · Hyaluronidase (human recombinant)
  2. Indication

    Advanced Esophageal Adenocarcinoma

    go.drugbank.com/conditions/DBCOND0129586
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  3. Indication

    Advanced Gastric Carcinoma

    go.drugbank.com/conditions/DBCOND0032323
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  4. Indication

    Completely resected Stage IIB melanoma

    go.drugbank.com/conditions/DBCOND0160974
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  5. Indication

    Completely resected Stage III melanoma

    go.drugbank.com/conditions/DBCOND0160976
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  6. Indication

    Completely resected Stage IV melanoma

    go.drugbank.com/conditions/DBCOND0160977
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  7. Indication

    Resected Esophageal Cancer

    go.drugbank.com/conditions/DBCOND0149150
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  8. Indication

    Urothelial Carcinoma

    go.drugbank.com/conditions/DBCOND0039277
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  9. Indication

    Completely resected Stage IIC melanoma

    go.drugbank.com/conditions/DBCOND0160975
    Drugs: Hyaluronidase (human recombinant) · Nivolumab
  10. Indication

    Primary Immune Deficiency Disorders (PIDD)

    go.drugbank.com/conditions/DBCOND0038807
    Drugs: Hyaluronidase (human recombinant)